Profile data is unavailable for this security.
About the company
Akari Therapeutics, Plc is a late-stage biotechnology company. The Company is developing advanced therapies for autoimmune and inflammatory diseases. Its lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Its pipeline includes a Phase 3 clinical trial program investigating nomacopan for pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). It is conducting a clinical trial of subcutaneous nomacopan for the treatment of HSCT-TMA in pediatrics. The United States Food and Drug Administration (FDA) has granted Rare Pediatric Disease, Orphan Drug, and Fast Track designations to nomacopan for the treatment of pediatric HSCT-TMA. It is also investigating long-acting PASylated-nomacopan (PAS-nomacopan) for treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (dry AMD) in preclinical studies.
- Revenue in USD (TTM)0.00
- Net income in USD-10.01m
- Incorporated2004
- Employees9.00
- LocationAkari Therapeutics PLC22 BOSTON WHARF ROAD, FL 7BOSTON 02210United StatesUSA
- Phone+1 (646) 350-0702
- Fax+1 (646) 843-9352
- Websitehttps://www.akaritx.com/
More ▼
Mergers & acquisitions
| Acquired company | AKTX:NAQ since announced | Transaction value |
|---|---|---|
| Peak Bio Inc | -28.89% | -- |
Data delayed at least 15 minutes, as of May 10 2024 20:57 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Monopar Therapeutics Inc | 0.00 | -7.61m | 11.73m | 10.00 | -- | -- | -- | -- | -0.5289 | -0.5289 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -73.36 | -54.07 | -92.67 | -60.60 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 20.10 | -- | -- | -- |
| Chemomab Therapeutics Ltd - ADR | 0.00 | -24.22m | 11.93m | 20.00 | -- | 0.0351 | -- | -- | -42.37 | -42.37 | 0.00 | 23.93 | 0.00 | -- | -- | 0.00 | -74.28 | -- | -90.33 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.39 | -- | -- | -- |
| Pioneer Green Farms Inc | 9.29k | -403.37k | 11.94m | 6.00 | -- | -- | -- | 1,285.15 | -0.0172 | -0.0172 | 0.0004 | -0.026 | 0.0154 | 0.3035 | -- | 1,548.33 | -66.94 | -- | -- | -- | 41.44 | -- | -4,341.98 | -- | 0.0106 | -30.89 | -- | -- | -- | -- | 35.41 | -- | -- | -- |
| 22nd Century Group Inc | 32.20m | -64.68m | 12.08m | 64.00 | -- | -- | -- | 0.3752 | -49.97 | -116.47 | 29.49 | -3.09 | 0.4531 | 5.70 | 8.81 | 503,187.50 | -76.94 | -46.78 | -105.06 | -54.18 | -27.00 | -2.11 | -169.81 | -107.95 | 0.4766 | -4.62 | 2.39 | -- | -20.49 | 4.03 | -76.94 | -- | 53.60 | -- |
| Energy Finders Inc | 4.06m | -2.92m | 12.30m | 46.00 | -- | -- | -- | 3.03 | -0.272 | -0.272 | 1.52 | 3.04 | -- | -- | -- | 88,304.35 | -- | -- | -- | -- | 27.45 | -- | -71.79 | -- | 0.6706 | -12.57 | 0.564 | -- | -- | -- | -- | -- | -- | -- |
| Dominari Holdings Inc | 2.04m | -22.88m | 12.57m | 26.00 | -- | 0.2376 | -- | 6.17 | -4.44 | -4.44 | 0.3899 | 8.92 | 0.0305 | -- | 0.3829 | 78,423.08 | -34.20 | -26.82 | -35.10 | -27.45 | -- | -- | -1,122.22 | -3,353.52 | -- | -- | 0.00 | -- | -- | 135.75 | 12.72 | -- | 63.99 | -- |
| Endexx Corp | 4.64m | 6.93m | 12.61m | -- | 1.87 | -- | 2.13 | 2.72 | 0.0133 | 0.0133 | 0.0091 | -0.0255 | 0.6773 | 4.37 | 13.54 | -- | 86.51 | -- | -- | -- | 28.73 | -- | 127.74 | -- | 0.0664 | -- | -- | -- | 228.66 | -- | 28.26 | -- | -- | -- |
| Akari Therapeutics PLC (ADR) | 0.00 | -10.01m | 12.68m | 9.00 | -- | -- | -- | -- | -2.04 | -2.04 | 0.00 | -0.0346 | 0.00 | -- | -- | 0.00 | -110.06 | -149.95 | -1,281.64 | -435.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 43.61 | -- | -- | -- |
| Kiora Pharmaceuticals Inc | 0.00 | -13.04m | 12.77m | 12.00 | -- | 0.6132 | -- | -- | -2.98 | -2.98 | 0.00 | 0.7929 | 0.00 | -- | -- | 0.00 | -77.27 | -70.52 | -91.06 | -81.86 | -- | -- | -- | -2,040.61 | -- | -- | 0.00 | -- | -- | -- | 3.97 | -- | -- | -- |
| Check Cap Ltd | 0.00 | -17.62m | 12.81m | 85.00 | -- | 0.4677 | -- | -- | -3.01 | -3.01 | 0.00 | 4.68 | 0.00 | -- | -- | 0.00 | -44.86 | -58.80 | -48.21 | -66.41 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.08 | -- | 16.04 | -- |
| Imunon Inc | 0.00 | -19.51m | 12.97m | 33.00 | -- | 0.9689 | -- | -- | -2.17 | -2.17 | 0.00 | 1.42 | 0.00 | -- | -- | 0.00 | -59.23 | -50.18 | -80.53 | -60.27 | -- | -- | -- | -5,725.88 | -- | -- | 0.00 | -- | -100.00 | -- | 45.64 | -- | 26.69 | -- |
| Microbot Medical Inc | 0.00 | -10.74m | 13.29m | 22.00 | -- | 2.40 | -- | -- | -1.08 | -1.08 | 0.00 | 0.3845 | 0.00 | -- | -- | 0.00 | -120.24 | -53.28 | -178.87 | -62.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.44 | -- | -31.76 | -- |
| Psyence Biomedical Ltd | 0.00 | 1.52m | 13.39m | -- | -- | -- | 8.84 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
| Enzolytics Inc | 0.00 | -119.19k | 13.55m | 2.00 | -- | -- | -- | -- | -0.106 | -0.106 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -369.52 | -- | -- | -- | -- | -- | -- | -- | -- | -4.30 | -- | -- | -100.00 | -- | -9.35 | -- | -- | -- |
| Nexgel Inc | 4.09m | -3.16m | 13.68m | 19.00 | -- | 2.69 | -- | 3.35 | -0.5566 | -0.5566 | 0.7212 | 0.818 | 0.4027 | 3.81 | 9.57 | 215,263.20 | -31.39 | -44.61 | -38.80 | -56.19 | 15.16 | 5.02 | -77.95 | -180.98 | 1.46 | -- | 0.1396 | -- | 99.66 | 13.06 | 33.48 | -- | -- | -- |
Data as of May 10 2024. Currency figures normalised to Akari Therapeutics PLC's reporting currency: US Dollar USD
4.42%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sabby Management LLCas of 31 Dec 2023 | 164.03k | 2.48% |
| Omnia Family Wealth LLCas of 31 Mar 2024 | 87.63k | 1.33% |
| Cerity Partners LLCas of 31 Dec 2023 | 23.64k | 0.36% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 10.27k | 0.16% |
| BG Fund Management Luxembourg SAas of 31 Dec 2023 | 6.11k | 0.09% |
| Bank of America, NA (Private Banking)as of 31 Dec 2023 | 150.00 | 0.00% |
| Truvestments Capital LLCas of 31 Dec 2023 | 50.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 8.00 | 0.00% |
| Tower Research Capital LLCas of 31 Dec 2023 | 7.00 | 0.00% |
| Cornerstone Planning Group LLCas of 31 Mar 2024 | 5.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
